4th Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Administration of the cost sharing reduction subsidy - proposed rule Benefit and Payment Parameters Essential health benefits - proposed rule for Standards Related to Essential Health Benefits

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

H.R. 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act (pharmacy audits) Proposed rule - Standards Related to Essential Health Benefits

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1058 (112th), H.R. 1971 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.